Anaptysbio, Inc. · NASDAQ:ANAB
Morgan Stanley's stake in Anaptysbio, Inc. fell to 3.60% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Morgan Stanley's stake in Anaptysbio, Inc. fell to 3.60%, 1,006,063 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 3.60%
- Shares
- 1,006,063
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 3.60% | 1,006,063 |
| Morgan Stanley Capital Services LLC | 3.20% | 879,351 |
Source
Related
- Anaptysbio, Inc.
- Morgan Stanley
- Anaptysbio, Inc. shareholders
- Schedule 13G · Morgan Stanley · Aug 5, 2025
- Form 4 · Renton Hollings · Oct 2, 2026
- Form 4 · Orwin John A · Sep 17, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Schmid John P. · Jun 17, 2026
- Form 4 · Renton Hollings · Jun 17, 2026